Clinical Trials in Houston

Showing 2901-2920 of 15,366 trials

Phase Ib Study of AlpeliSib With PEmbroLizumab in Patients With mEtastatic Breast caNcer or melanomA (SELENA)

NCT06545682

To find a recommended dose of the combination of alpelisib and pembrolizumab that can be given to patients with metastatic breast cancer or melanoma.

Melanoma (Skin Cancer)Breast CancerBrain Metastasases

M.D. Anderson Cancer Center50 participantsStarted Oct 2024

Houston, Texas, United States

RECRUITINGPhase 1< 1 mile

A Phase Ib Trial of Eribulin in Combination With Irinotecan and Temozolamide in Children With Relapsed or Refractory Solid Tumors

NCT06006273

To find the recommended dose of eribulin that can be given in combination with irinotecan and temozolomide to treat relapsed and/or refractory solid tumors.

Refractory Solid Tumors

M.D. Anderson Cancer Center48 participantsStarted Aug 2023

Houston, Texas, United States

Not Yet Recruiting< 1 mile

Nanosecond Pulsed Field Ablation in the Management of Benign Thyroid Nodules

NCT07226804

To observe the outcomes of nsPFA therapy to treat benign thyroid nodules.

Thyroid NodulesPulsed Field Ablation

M.D. Anderson Cancer Center30 participantsStarted Apr 2026

Houston, Texas, United States

Active Not RecruitingNA< 1 mile

PancFit: Multimodal Exercise During Preoperative Therapy for Pancreatic Cancer

NCT03187951

Any time the words "you," "your," "I," or "me" appear, it is meant to apply to the potential participant. The goal of this clinical research study is to learn if regular exercise and behavioral skills training can help to improve physical activity in patients with pancreatic cancer who are scheduled to receive chemotherapy and/or radiation before standard-of-care surgery. This is an investigational study. Up to 128 participants will be enrolled on this study. All will take part at MD Anderson.

Other Disorders of Glucose Regulation and Pancreatic Internal SecretionPancreatic Cancer

M.D. Anderson Cancer Center152 participantsStarted Jun 2017

Houston, Texas, United States

Phase Ib Study of AlpeliSib With PEmbroLizumab in Patients With mEtastatic Breast caNcer or melanomA (SELENA)

A Phase Ib Trial of Eribulin in Combination With Irinotecan and Temozolamide in Children With Relapsed or Refractory Solid Tumors

Nanosecond Pulsed Field Ablation in the Management of Benign Thyroid Nodules

PancFit: Multimodal Exercise During Preoperative Therapy for Pancreatic Cancer

Find Trials by Condition in Houston

Smoking Cessation Treatment for Head & Neck Cancer Patients

INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)

Formulating Expert Consensus Guidelines in Cancer Care Using the Delphi Method

Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

Anamorelin Hydrochloride, Physical Activity, and Nutritional Counseling in Decreasing Cancer-Related Fatigue in Patients With Incurable Metastatic or Recurrent Solid Tumors

The Effect of Guided Care With Vectra Compared to Treatment as Usual in Patients With Rheumatoid Arthritis

A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With GEP-NET

Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced Cancer

A Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of TERN-601 in Adults With Overweight or Obesity

A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

Multi-center MRD Registry for Inflammatory Breast Cancer

Phase 2a Placebo-Controlled Study of VTX3232 Alone or in Combination With Semaglutide in Obesity

R-5280 in Newly Diagnosed Patients With Type 1 Diabetes

A Study of the Natural History of Participants With LGMD2E/R4, LGMD2D/R3, LGMD2C/R5, and LGMD2A/R1 ≥ 4 Years of Age, Who Are Managed in Routine Clinical Practice

Efficacy, Safety & Pharmacokinetic (PK) Study of HLD200 in Children Aged 4-5 Years With ADHD